Therefore, it is reasonable to assume that the presence of gene variants encoding for regulatory and catalytic antioxidant proteins, such as NRF2, GTSM3, SOD2 and GPX3 polymorphisms, functionally resulting in altered levels of antioxidant defense, may affect the risk of tumor development, including testicular tumors. The gene discussed is GPX3; the disease is neoplasm.